Wearable activity tracker study exploring rheumatoid arthritis patients' disease activity using patient-reported outcome measures, clinical measures, and biometric sensor data (the wear study)
- PMID: 38444876
- PMCID: PMC10912436
- DOI: 10.1016/j.conctc.2024.101272
Wearable activity tracker study exploring rheumatoid arthritis patients' disease activity using patient-reported outcome measures, clinical measures, and biometric sensor data (the wear study)
Abstract
Background: Digital health studies using electronic patient reported outcomes (ePROs), wearables, and clinical data to provide a more comprehensive picture of patient health.
Methods: Newly initiated patients on upadacitinib or adalimumab for RA will be recruited from community settings in the Excellence NEtwork in RheumatoloGY (ENRGY) practice-based research network. Over the period of three to six months, three streams of data will be collected (1) linkable physician-derived data; (2) self-reported daily and weekly ePROs through the ArthritisPower registry app; and (3) biometric sensor data passively collected via wearable. These data will be analyzed to evaluate correlations among the three types of data and patient improvement on the newly initiated medication.
Conclusions: Results from this study will provide valuable information regarding the relationships between physician data, wearable data, and ePROs in patients newly initiating an RA treatment, and demonstrate the feasibility of digital data capture for Remote Patient Monitoring of patients with rheumatic disease.
Keywords: Mobile technology; Patient-generated health data; Patient-reported outcomes; Patients; Real world data; Real world evidence; Rheumatoid arthritis; Wearable digital technology.
© 2024 The Authors.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. Global Healthy Living Foundation receives grants, sponsorships and contracts from pharmaceutical manufacturers and private foundations. A full list of GHLF funders is publicly available here: https://www.ghlf.org/our-partners/ PZ is employed by 10.13039/100006483AbbVie. JRC receives grants from 10.13039/100000960ACR, 10.13039/100006483AbbVie, 10.13039/100002429Amgen, ArthritisPower, Aqtual, Bendcare, 10.13039/100002491BMS, CorEvitas, FASTER, 10.13039/100004330GSK, IlluminationHealth, Janssen, Labcorp, 10.13039/100004312Lilly, 10.13039/100016939Myriad, 10.13039/100008272Novartis, 10.13039/100004319Pfizer, 10.13039/100004339Sanofi, Scipher, Setpoint, 10.13039/100006978UCB, United Rheumatology. He has received honorariums from 10.13039/100000960ACR, 10.13039/100006483Abbvie, 10.13039/100002429Amgen, ArthritisPower, Aqtual, Bendcare, BMS, CorEvitas, FASTER, GSK, IlluminationHealth, Janssen, Labcorp, 10.13039/100004312Lilly Myriad, 10.13039/100004336Novartis, Revero, 10.13039/100004319Pfizer, 10.13039/100004339Sanofi, Scipher, Setpoint, TNacity, Blue Ocean, 10.13039/100006978UCB.
Similar articles
-
Digital Tracking of Rheumatoid Arthritis Longitudinally (DIGITAL) Using Biosensor and Patient-Reported Outcome Data: Protocol for a Real-World Study.JMIR Res Protoc. 2019 Sep 26;8(9):e14665. doi: 10.2196/14665. JMIR Res Protoc. 2019. PMID: 31573949 Free PMC article.
-
Participant Engagement and Adherence to Providing Smartwatch and Patient-Reported Outcome Data: Digital Tracking of Rheumatoid Arthritis Longitudinally (DIGITAL) Real-World Study.JMIR Hum Factors. 2023 Nov 7;10:e44034. doi: 10.2196/44034. JMIR Hum Factors. 2023. PMID: 37934559 Free PMC article.
-
A Real-World Effectiveness Study Using a Mobile Application to Evaluate Early Outcomes with Upadacitinib in Rheumatoid Arthritis.Rheumatol Ther. 2023 Dec;10(6):1519-1533. doi: 10.1007/s40744-023-00594-6. Epub 2023 Sep 20. Rheumatol Ther. 2023. PMID: 37728861 Free PMC article.
-
Digital technology for delivering and monitoring exercise programs for people with cystic fibrosis.Cochrane Database Syst Rev. 2023 Jun 9;6(6):CD014605. doi: 10.1002/14651858.CD014605.pub2. Cochrane Database Syst Rev. 2023. PMID: 37294546 Free PMC article. Review.
-
Digital Interventions to Build a Patient Registry for Rheumatology Research.Rheum Dis Clin North Am. 2019 May;45(2):173-186. doi: 10.1016/j.rdc.2019.01.009. Rheum Dis Clin North Am. 2019. PMID: 30952391 Review.
Cited by
-
A systematic review of passive data for remote monitoring in psychosis and schizophrenia.NPJ Digit Med. 2025 Jan 27;8(1):62. doi: 10.1038/s41746-025-01451-2. NPJ Digit Med. 2025. PMID: 39870797 Free PMC article.
-
Rheumatology in the digital health era: status quo and quo vadis?Nat Rev Rheumatol. 2024 Dec;20(12):747-759. doi: 10.1038/s41584-024-01177-7. Epub 2024 Oct 31. Nat Rev Rheumatol. 2024. PMID: 39482466 Review.
References
-
- Bourke A., Dixon W.G., Roddam A., Lin K.J., Hall G.C., Curtis J.R., et al. Incorporating patient generated health data into pharmacoepidemiological research. Pharmacoepidemiol Drug Saf. 2020;29(12) 1540–9. - PubMed
-
- de Jong C.M.M., de Wit K., Black S.A., Gwozdz A.M., Masias C., Parks A.L., et al. Use of patient-reported outcome measures in patients with venous thromboembolism: communication from the ISTH SSC Subcommittee on Predictive and Diagnostic Variables in Thrombotic Disease. J Thromb Haemost. 2023;21(10) 2953–62. - PubMed
LinkOut - more resources
Full Text Sources